Findings show promise for developing potential new anti-inflammatory drugs and treatments for autoimmune diseases.
Category: Research Highlight
GlycoNet researchers are studying a group of molecules that could provide insight into treating and monitoring neurodegenerative diseases.
Scientists discover a cellular mechanism that may yield insights into improving vaccines and better understanding cancer and autoimmune diseases.
A carbohydrate-derived drug shows promise as a treatment to slow progression of the most common form of muscular dystrophy.
GlycoNet researchers have made exciting advances in understanding Alzheimer’s disease and are developing a potential therapeutic strategy.
GlycoNet researchers studying complex enzymes gain insight into how some pathogens could potentially be targeted without antibiotics.
Understanding the process could help scientists look out for new, more infectious variants, say GlycoNet researchers.
A natural compound that slows the breakdown of starch could be used to develop a more pleasant treatment for managing Type 2 diabetes.
Knowledge in the sugars that coat blood vessels helps researchers find a way to reduce organ rejection.
GlycoNet Investigators study the sugars on red blood cells to find ways to make universal donor blood